Clinical Trials Directory

Trials / Completed

CompletedNCT06969131

Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors

The Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
South Valley University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aimed to identify predictive factors associated with the achievement of pentafecta outcomes following partial nephrectomy.

Detailed description

Partial nephrectomy (PN) is widely considered the preferred treatment for clinical T1 (cT1) renal masses, primarily because it preserves kidney function more effectively than radical nephrectomy. The trifecta metric includes three components: warm ischemia time (WIT) of ≤ 25 minutes or cold ischemia time (CIT) of ≤ 60 minutes, negative surgical margins, and the absence of perioperative major complications. The pentafecta expands upon these criteria by adding two additional parameters: preservation of ≥ 90% of the estimated glomerular filtration rate (eGFR) and no progression in chronic kidney disease (CKD) stage within 12 months postoperatively.

Conditions

Interventions

TypeNameDescription
PROCEDUREOpen Partial NephrectomyPatients underwent open partial nephrectomy.
PROCEDURELaparoscopic Partial NephrectomyPatients underwent laparoscopic partial nephrectomy.

Timeline

Start date
2022-05-01
Primary completion
2024-05-01
Completion
2024-05-01
First posted
2025-05-13
Last updated
2025-05-13

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06969131. Inclusion in this directory is not an endorsement.